Detection of circulating tumour DNA in patients with aggressive B‐cell non‐Hodgkin lymphoma
- 25 June 2013
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 163 (1), 123-126
- https://doi.org/10.1111/bjh.12439
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemiaBlood, 2012
- Comparison of Minimal Residual Disease Detection Using High-Throughput Sequencing and Allele-Specific Oligonucleotide PCR Methods in Pediatric B-Lineage Acute Lymphoblastic Leukemia.Blood, 2012
- Minimal Residual Disease Quantification in Acute Lymphoblastic Leukemia Using High-Throughput Sequencing of Multiple Immunoreceptor Genes Predicts Relapse and Survival After Allogeneic Hematopoietic Cell Transplantation.Blood, 2012
- Deep B and T Cell Repertoire Sequencing to Evaluate Minimal Residual Disease and T Cell Responses in a Therapeutic Vaccine Trial for Mantle Cell LymphomaBlood, 2012
- High-Throughput Immunoglobulin Gene Sequencing Quantifies Minimal Residual Disease in CLL with 10e-6 Sensitivity and Strongly Predicts Relapse After Allogeneic Hematopoietic Cell TransplantationBlood, 2011
- Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigmsHematological Oncology, 2011
- If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphomaBMC Cancer, 2010
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993